AAP News Vol. 1 No. 3 March 1985, p. 7
© 1985 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Study aimed at lowering retardation rate in children of mothers affected by PKU

A collaborative study designed to reduce the rate of mental retardation and other congenital defects occurring in the offspring of mothers with controlled phenylketonuria (PKU) has been launched by the National Institute of Child Health and Human Development (NICHD) and four medical centers.

A congenital metabolic disorder in which the body is unable to convert phenylalanine into tyrosine, PKU occurs in one of every 14,000 births, or five newborns a week, in the United States.